Send us a text

In this episode of the Life Science Success Podcast, my guest is Dr. Vlad Vitoc, Chairman of the Board, CEO, and President of MAIA Biotechnology. Dr. Vitoc shares his journey from practicing medicine in Romania to leading a cutting-edge biotech company in the United States. We explore MAIA Biotechnology's innovative approach to cancer treatment, focusing on telomere-targeting therapeutics and their lead compound, THIO. Dr. Vitoc offers insights into the challenges of developing new cancer therapies, the future of targeted treatments, and how his international background influences his leadership style.

He also discusses the balance between scientific innovation and commercial viability in the biotech industry. This episode provides a fascinating look into the intersection of medical expertise, business acumen, and scientific innovation in the fight against cancer.

00:00 Introduction to Life Science Success Podcast

00:43 Sponsor Message from D3 Digital Media Marketing

01:24 Introducing Dr. Vlad Vitoc

02:00 Dr. Vitoc's Journey in Oncology

10:08 Innovations in Cancer Treatment

17:20 Challenges and Future Plans

26:35 Global Clinical Development Strategy

28:11 Closing Remarks and Reflections

40:16 Podcast Conclusion and Call to Action

ETF Edge

Embracing Leverage & Chances of a Recession 06/01/22

Remember Everything You Learn from Podcasts